Take a look at some of Wednesday's midday movers:» Read More
NEW YORK, July 17- Fed Chair Janet Yellen may have surprised the markets this week by noting that valuations in some parts of the U.S. stock market look stretched but mutual fund managers mostly greeted her comments with a shrug.
Some of Tuesday's midday movers:
Some of the names on the move ahead of the open.
Some of Monday's midday movers.
Tuesday's midday movers:
Check out which companies are making headlines after the bell Tuesday:
Tuesday’s retail sales should be an important check up on consumers and could show they are picking up their pace of spending.
Biotech and drug companies say the benefits of genome research are on the way, and just as importantly, advances are pushing the technology toward affordability.
The Supreme Court unanimously ruled that human genes cannot be patented, with CNBC's Bertha Coombs; David Resnick, Nixon Peabody LLP; Mitch Epner, Wilk Auslander Counsel; and Rich Lowry, National Review.
A unanimous Supreme Court decision barred patents on naturally occurring DNA, but analysts said the ruling did little harm to biotech companies.
CNBC's Bertha Coombs reports shares of Myriad Genetics are hitting an all-time high after the Supreme Court ruled a naturally occurring human gene cannot be patented, but upheld key DNA patents of Myriad's BRACAnalysis test.
The Supreme Court ruled a naturally occurring human gene cannot be patented, but upheld key DNA patents of Myriad's BRACAnalysis test. CNBC's Bertha Coombs reports.
A check on biotech stocks after the Supreme Court justices say naturally occurring human genes cannot be patented, with CNBC's Seema Mody.
Shares of genetic test maker rose 4 percent, after actress Anjolina Jolie said to undergo double-mastectomy, following testing which showed she carried a gene for breast cancer.
The Supreme Court will hear arguments in a case that calls into question whether DNA can be claimed as intellectual property, and remain off limits without the permission of the patent holder.
Take a look at some of Thursday's midday movers:
Check out which companies are making headlines after the bell Monday.
Take a look at some of Monday's midday movers:
Cramer makes the call on viewers' favorite stocks.
Here's why you should keep a close eye on these six stocks.